Prognostic PSMA-PET PROMISE nomograms for patients with prostate cancer

被引：0
|
作者：
Fendler, Wolfgang Peter
Karpinski, Madeleine J.
Huesing, Johannes
Claassen, Kevin
Moeller, Lennart
Kajueter, Hiltraud
Oesterling, Florian
Gruenwald, Viktor
Umutlu, Lale
Lanzafame, Helena
Telli, Tugce
Merkel-Jens, Anja
Huesing, Anika
Kesch, Claudia
Herrmann, Ken
Stang, Andreas
Hadaschik, Boris A.
机构：
[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Nucl Med, West German Canc Ctr, Essen, Germany
[2] DKTK & NCT Univ Hosp Essen, Dept Nucl Med, Essen, Germany
[3] Canc Registry North Rhine Westphalia gGmbH, Bochum, Germany
[4] Canc Registry North Rhine Westphalia, Bochum, Germany
[5] Univ Duisburg Essen, Clin Internal Med Tumor Res, Essen, Germany
[6] Univ Duisburg Essen, Dept Urol, Essen, Germany
[7] Univ Hosp Essen, German Canc Consortium DKTK, Essen, Germany
[8] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany
[9] Univ Duisburg Essen, Dept Nucl Med, Essen, Germany
[10] Univ Klinikum Aoe Essen Imibe, Essen, Germany
[11] Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany
[12] Univ Duisburg Essen, Univ Hosp Essen, Dept Urol, Essen, Germany
[13] Canc Registry North Rhine Westphalia, Bochum, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5016
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Future treatment strategies for prostate cancer guided by PSMA-PET
    Watabe, Tadashi
    ANNALS OF ONCOLOGY, 2022, 33 : S453 - S453
  • [22] PSMA-PET to detect prostate cancer recurrence after radiotherapy
    Alghazo, Omar
    O'Callaghan, Michael
    NATURE REVIEWS UROLOGY, 2023, 20 (01) : 5 - 6
  • [23] Voxel-based PSMA-PET/histopathology analysis in patients with primary prostate cancer
    Zamboglou, C.
    Schiller, F.
    Fechter, T.
    Drendel, V.
    Jilg, C. A.
    Meyer, P. T.
    Mix, M.
    Grosu, A. L.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S448 - S449
  • [24] Prostate-specific membrane antigen targeting positron emission tomography (PSMA-PET) in prostate cancer: PSMA-RADS classification and PROMISE criterias
    Robin, P.
    Palard-Novello, X.
    Bailly, C.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2023, 47 (05): : 270 - 275
  • [25] Primary staging with PSMA-PET improves the prediction of prostate cancer recurrence
    Yirga, Leubet
    Hadaschik, Boris
    Puellen, Lukas
    UROLOGIE, 2023, : 1326 - 1327
  • [26] PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer?
    Laura Evangelista
    Pierpaolo Alongi
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1709 - 1711
  • [27] PSMA-PET
    Denis, A.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2019, 43 (03): : 287 - 294
  • [28] Current role of PSMA-PET imaging in the clinical management of prostate cancer
    Georgakopoulos, Alexander
    Bamias, Aristotle
    Chatziioannou, Sophia
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [29] COMPARING PSMA-PET/CT TO MPMRI AND HISTOPATHOLOGY FOR STAGING PROSTATE CANCER
    Berger, Israel
    Annabattula, Chandra
    Lewis, Jeffrey
    Shetty, Deepa V.
    Winter, Matthew
    Loh, Han
    Varol, Celi
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 51 - 51
  • [30] PSMA-PET: is the time to say goodbye to metabolic radiopharmaceuticals in prostate cancer?
    Evangelista, Laura
    Alongi, Pierpaolo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (06) : 1709 - 1711
12345